There has been a lot of noise in the past week about the effectiveness of lutetium-177 linked to PSMA in the treatment of late stage prostate cancer. If you were looking for us to say something about this, Allen Edel already has, back in October last year, when the relevant article was first published on line and Allen promptly commented (click here to get his take).
Filed under: Uncategorized |
I seem to have missed the Lu-177 chatter